BioNTech (BNTX) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free BNTX Stock Alerts $87.21 +0.50 (+0.58%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCOVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battlemsn.com - April 26 at 5:12 PM103,858 Shares in BioNTech SE (NASDAQ:BNTX) Acquired by abrdn plcmarketbeat.com - April 26 at 6:13 AMWhat's Going On With Pfizer Stock On Thursday?msn.com - April 25 at 6:44 PMGSK sues Pfizer, BioNTech over COVID-19 vaccines patentsmsn.com - April 25 at 1:43 PMGlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyreuters.com - April 25 at 9:40 AMMackenzie Financial Corp Has $2.30 Million Stake in BioNTech SE (NASDAQ:BNTX)marketbeat.com - April 23 at 5:11 AMBioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024globenewswire.com - April 22 at 6:45 AMBioNTech SE to Post Q1 2024 Earnings of $1.26 Per Share, HC Wainwright Forecasts (NASDAQ:BNTX)americanbankingnews.com - April 22 at 1:36 AMBioNTech SE (NASDAQ:BNTX) Shares Sold by Vontobel Holding Ltd.marketbeat.com - April 18 at 6:14 AMBioNTech (NASDAQ:BNTX) Given "Buy" Rating at HC Wainwrightamericanbankingnews.com - April 18 at 5:42 AMFlossbach Von Storch AG Boosts Stock Position in BioNTech SE (NASDAQ:BNTX)marketbeat.com - April 17 at 10:12 PMBioNTech (NASDAQ:BNTX) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - April 17 at 3:30 PMAssessing BioNTech: Insights From 11 Financial Analystsmarkets.businessinsider.com - April 17 at 2:29 PMBioNTech (NASDAQ:BNTX) Sees Unusually-High Trading Volumemarketbeat.com - April 16 at 12:45 PMBioNTech (NASDAQ:BNTX) Trading Up 2.7%marketbeat.com - April 15 at 5:31 PMBaillie Gifford & Co. Buys 86,343 Shares of BioNTech SE (NASDAQ:BNTX)marketbeat.com - April 9 at 12:11 PMBioNTech SE (NASDAQ:BNTX) Shares Bought by LA Financiere DE L Echiquiermarketbeat.com - April 8 at 2:14 PMThree-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancerglobenewswire.com - April 7 at 2:00 PMDekaBank Deutsche Girozentrale Buys 127,951 Shares of BioNTech SE (NASDAQ:BNTX)marketbeat.com - April 7 at 12:17 PMBioNTech SE (NASDAQ:BNTX) Short Interest Up 5.5% in Marchmarketbeat.com - April 5 at 1:58 AMBioNTech SE (NASDAQ:BNTX) Shares Bought by Fifth Third Bancorpmarketbeat.com - April 4 at 5:09 AMThe 3 Best Bargain Stocks to Buy in Q2 2024investorplace.com - March 31 at 3:39 PMBioNTech SE (NASDAQ:BNTX) Stock Holdings Reduced by SG Americas Securities LLCmarketbeat.com - March 31 at 4:16 AMBioNTech (NASDAQ:BNTX) Price Target Cut to $101.00marketbeat.com - March 27 at 3:09 PM3 Biotech Stocks to Buy for the Next Bull Run: March 2024investorplace.com - March 26 at 6:44 AMThis Vaccine Maker Sits on Cash Almost Equal to Its Market Valuefinance.yahoo.com - March 26 at 3:19 AMOptimistic Outlook for BioNTech: A Buy Rating Amidst Vaccine Demand and Strong Oncology Pipelinemarkets.businessinsider.com - March 25 at 4:47 AMBioNTech Full Year 2023 Earnings: Misses Expectationsfinance.yahoo.com - March 24 at 6:46 PMEarnings Miss: BioNTech SE Missed EPS By 14% And Analysts Are Revising Their Forecastsfinance.yahoo.com - March 23 at 12:14 PMBioNTech (NASDAQ:BNTX) PT Lowered to $90.00marketbeat.com - March 22 at 2:10 PMBioNTech Tumbles as Q4 Profit, Sales Trail Estimates on Falling COVID-19 Vaccine Demandmsn.com - March 22 at 1:10 AMWhy Is BioNTech Stock Trading Lower On Wednesday?msn.com - March 21 at 3:06 PMAnalysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Edwards Lifesciences (EW) and Innovent Biologics (OtherIVBXF)markets.businessinsider.com - March 21 at 3:06 PMHold Rating for BioNTech: Navigating Vaccine Revenue Decline and Prospective Oncology Pipelinemarkets.businessinsider.com - March 21 at 3:06 PMBioNTech SE (NASDAQ:BNTX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 21 at 3:06 PMBioNTech (NASDAQ:BNTX) Price Target Cut to $123.00marketbeat.com - March 21 at 1:56 PMCanaccord Genuity Group Reaffirms "Buy" Rating for BioNTech (NASDAQ:BNTX)marketbeat.com - March 21 at 11:48 AMMaintaining Hold on BioNTech: A Balancing Act Between Near-Term Challenges and Long-Term Oncology Investmentmarkets.businessinsider.com - March 21 at 2:16 AMBioNTech slides as earnings plunge amid cancer drug shiftmsn.com - March 20 at 4:15 PMPfizer partner BioNTech ekes out Q4 profit despite 65% revenue dropseekingalpha.com - March 20 at 4:15 PMBioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financialsfinance.yahoo.com - March 20 at 4:15 PMBioNTech Q4 Net Profit Plummets rttnews.com - March 20 at 3:03 PMBioNTech's Brew: Mixing COVID Legacy With Oncology Ambitionsseekingalpha.com - March 20 at 2:43 PMBNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q4 2023investorplace.com - March 20 at 11:08 AMBioNTech (NASDAQ:BNTX) Hits New 52-Week Low at $85.67marketbeat.com - March 20 at 11:02 AMBioNTech Earnings Fall Short of Estimates. The Stock Is Down.barrons.com - March 20 at 7:44 AMBioNTech SE: BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Updatefinanznachrichten.de - March 20 at 6:44 AMAfter earnings plunge, BioNTech pins hopes on cancer drug launchesreuters.com - March 20 at 6:18 AMBioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Updateglobenewswire.com - March 20 at 6:15 AMBioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officerglobenewswire.com - March 20 at 6:00 AM Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> BNTX Media Mentions By Week BNTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼0.540.32▲Average Medical News Sentiment BNTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼119▲BNTX Articles Average Week Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: argenx News Today Neurocrine Biosciences News Today Biogen News Today Bio-Techne News Today Repligen News Today Qiagen News Today Exelixis News Today Vaxcyte News Today Revolution Medicines News Today Moderna News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
